Previous 10 | Next 10 |
Now China claims US broke the negotiation agreement The market futures plunge after China threatens retaliation. Then China backtracks, and the market goes back up. China claims the US broke the agreement; we say China did. Am I the only one who is bored with the whole nonsense? All I can ...
Quick Take AtriCure ( ATRC ) announced it has agreed to acquire SentreHEART for $40 million plus additional contingent consideration of up to $260 million. SentreHEART is developing percutaneous left atrial appendage management solutions. With the deal, ATRC is gaining promising techno...
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has completed its previously announced acquisition of SentreHEART, Inc., a privately held developer of percutaneous left atrial a...
Investors appear to lack enthusiasm for AtriCure's ( ATRC -8.1% ) planned takeover of SentreHEART, the developer of a suture delivery device called LARIAT for left atrial appendage closure. More news on: AtriCure, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on t...
AtriCure (NASDAQ: ATRC ) has agreed to acquire privately held SentreHEART , a developer of percutaneous left atrial appendage management solutions. More news on: AtriCure, Inc., Healthcare stocks news, Merger & acquisition news, Read more ...
Acquisition Expands Addressable Market Opportunity and Complements Offerings for the Treatment of Atrial Fibrillation Announces Updates to 2019 Outlook Conference Call Monday, August 12 th at 8:30am ET AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atri...
The following slide deck was published by AtriCure, Inc. in conjunction with this Read more ...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...
AtriCure, Inc. (ATRC) Q2 2019 Results Conference Call July 30, 2019 04:30 PM ET Company Participants Lynn Lewis - Gilmartin Group Mike Carrel - President and Chief Executive Officer Andy Wade - Senior Vice President and Chief Financial Officer Conference Call Participants C...
News, Short Squeeze, Breakout and More Instantly...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Canaccord Genuity 44th...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it has received regulatory approval from the National Medical Products A...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its second quarter 2024 financial results on Tuesday, Ju...